Evidence for the functional interaction of two central neurotransmitters.
D000813:Anilides / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002934:Cinnamates / Q000494:pharmacology; D004298:Dopamine / Q000096:biosynthesis / Q000502:physiology*; D018492:Dopamine Antagonists; D004347:Drug Interactions; D010134:Fenclonine / Q000494:pharmacology; D007980:Levodopa / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D009127:Muscle Rigidity / Q000139:chemically induced; D018377:Neurotransmitter Agents / Q000378:metabolism*; D010293:Pargyline / Q000494:pharmacology; D010868:Pimozide / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000096:biosynthesis / Q000502:physiology*; D012702:Serotonin Antagonists; D013440:Sulfides / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects; D014202:Tremor / Q000139:chemically induced; D014364:Tryptophan / Q000494:pharmacology
D000813:Anilides; D002934:Cinnamates; D018492:Dopamine Antagonists; D008781:Methyltyrosines; D018377:Neurotransmitter Agents; D012702:Serotonin Antagonists; D013440:Sulfides; D010868:Pimozide; D012701:Serotonin; D007980:Levodopa; D014364:Tryptophan; D010293:Pargyline; D010134:Fenclonine; D004298:Dopamine; D008784:Methysergide